Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
December 6, 2014
Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases
Felix Muth, Marcel Günther, Silke M Bauer, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases
Pierre Koch, Rhalid Akkari, Andreas Brunschweiger, et al.
Journal of Medicinal Chemistry
|
December 16, 2016
Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3
Felix Muth, Ahmed El-Gokha, Francesco Ansideri, et al.
Journal of Medicinal Chemistry
|
February 27, 2015
Correction to Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases
Felix Muth, Marcel Günther, Silke M Bauer, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks
Fabian Heider, Tatu Pantsar, Mark Kudolo, et al.
Bioorganic & Medicinal Chemistry
|
September 24, 2016
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
Andreas Brunschweiger, Pierre Koch, Miriam Schlenk, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases
Bassam Abu Thaher, Martina Arnsmann, Frank Totzke, et al.
Frontiers in Chemistry
|
July 13, 2018
Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity
Pierre Koch, Andreas Brunschweiger, Vigneshwaran Namasivayam, et al.
ACS Omega
|
August 9, 2018
Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3
Francesco Ansideri, Joana T Macedo, Michael Eitel, et al.
Journal of Medicinal Chemistry
|
July 2, 2021
Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors
Stanislav Andreev, Tatu Pantsar, Roberta Tesch, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
December 6, 2014
Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases
Felix Muth, Marcel Günther, Silke M Bauer, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases
Pierre Koch, Rhalid Akkari, Andreas Brunschweiger, et al.
Journal of Medicinal Chemistry
|
December 16, 2016
Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3
Felix Muth, Ahmed El-Gokha, Francesco Ansideri, et al.
Journal of Medicinal Chemistry
|
February 27, 2015
Correction to Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases
Felix Muth, Marcel Günther, Silke M Bauer, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks
Fabian Heider, Tatu Pantsar, Mark Kudolo, et al.
Bioorganic & Medicinal Chemistry
|
September 24, 2016
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
Andreas Brunschweiger, Pierre Koch, Miriam Schlenk, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases
Bassam Abu Thaher, Martina Arnsmann, Frank Totzke, et al.
Frontiers in Chemistry
|
July 13, 2018
Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity
Pierre Koch, Andreas Brunschweiger, Vigneshwaran Namasivayam, et al.
ACS Omega
|
August 9, 2018
Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3
Francesco Ansideri, Joana T Macedo, Michael Eitel, et al.
Journal of Medicinal Chemistry
|
July 2, 2021
Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors
Stanislav Andreev, Tatu Pantsar, Roberta Tesch, et al.
Page
of 8